Brian Dall Schyth, Niels Lorenzen, Finn Skou Pedersen 

Slides:



Advertisements
Similar presentations
Volume 50, Issue 3, Pages (March 2009)
Advertisements

Volume 20, Issue 8, Pages (August 2012)
From: Skeletal Muscle Ryanodine Receptor Mutations Associated with Malignant Hyperthermia Showed Enhanced Intensity and Sensitivity to Triggering Drugs.
Volume 19, Issue 2, Pages (February 2011)
Volume 16, Issue 12, Pages (December 2008)
Volume 21, Issue 2, Pages (February 2013)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Targeted Nanoparticles Deliver siRNA to Melanoma
Volume 124, Issue 7, Pages (June 2003)
Volume 15, Issue 8, Pages (August 2007)
Molecular Therapy - Nucleic Acids
Volume 24, Issue 8, Pages (August 2016)
Volume 18, Issue 5, Pages (May 2010)
Volume 14, Issue 4, Pages (October 2006)
Volume 73, Issue 5, Pages (March 2008)
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 15, Issue 2, Pages (February 2007)
Volume 25, Issue 11, Pages (November 2017)
Tween 85-Modified Low Molecular Weight PEI Enhances Exon-Skipping of Antisense Morpholino Oligomer In Vitro and in mdx Mice  Mingxing Wang, Bo Wu, Jason.
Molecular Therapy - Nucleic Acids
Molecular Therapy - Methods & Clinical Development
Volume 15, Issue 11, Pages (November 2007)
Xiaoyin Xu, Zhong Yang, Qiang Liu, Yaming Wang  Molecular Therapy 
Development of Peptide-targeted Lipoplexes to CXCR4-expressing Rat Glioma Cells and Rat Proliferating Endothelial Cells  Wouter HP Driessen, Nobutaka.
Volume 15, Issue 6, Pages (June 2007)
Volume 18, Issue 12, Pages (December 2010)
Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma  Shinsuke Takagawa, Gabriella Lakos, Yasuji.
Volume 129, Issue 5, Pages (November 2005)
Volume 72, Issue 3, Pages (August 2007)
Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma  Alessandra Lopes, Kevin Vanvarenberg, Véronique Préat,
Molecular Therapy - Nucleic Acids
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
Volume 23, Issue 12, Pages (December 2015)
Volume 56, Issue 4, Pages (October 1999)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Volume 22, Issue 5, Pages (May 2014)
Volume 15, Issue 9, Pages (September 2007)
Volume 25, Issue 7, Pages (July 2017)
Volume 25, Issue 7, Pages (July 2017)
Protease-Activated Receptor 2, a Receptor Involved in Melanosome Transfer, is Upregulated in Human Skin by Ultraviolet Irradiation  Glynis Scott, Cristina.
Computer-assisted Hydrodynamic Gene Delivery
Volume 17, Issue 2, Pages (February 2009)
Volume 22, Issue 1, Pages (January 2014)
Volume 20, Issue 2, Pages (February 2012)
Robyn P. Hickerson, Frances J. D. Smith, Robert E
Md Nasimuzzaman, Danielle Lynn, Johannes CM van der Loo, Punam Malik 
Elizabeth M Hadac, Elizabeth J Kelly, Stephen J Russell 
In Vivo Tracking of Mesechymal Stem Cells Using Fluorescent Nanoparticles in an Osteochondral Repair Model  Jong Min Lee, Byung-Soo Kim, Haeshin Lee,
Volume 18, Issue 3, Pages (March 2010)
IL-17A Upregulates Keratin 17 Expression in Keratinocytes through STAT1- and STAT3- Dependent Mechanisms  Xiaowei Shi, Liang Jin, Erle Dang, Ting Chang,
Volume 26, Issue 1, Pages (January 2018)
Volume 15, Issue 11, Pages (November 2007)
Volume 17, Issue 10, Pages (October 2009)
Molecular Therapy - Nucleic Acids
Volume 24, Issue 1, Pages (January 2016)
Volume 16, Issue 4, Pages (April 2008)
Volume 20, Issue 5, Pages (May 2012)
Jennifer Altomonte, Sabrina Marozin, Roland M Schmid, Oliver Ebert 
Loss of Transgene following ex vivo Gene Transfer is Associated with a Dominant Th2 Response: Implications for Cutaneous Gene Therapy  Zhenmei Lu, Soosan.
Volume 15, Issue 9, Pages (September 2007)
Volume 20, Issue 4, Pages (April 2012)
Protein Transduction Domain-mediated Delivery of QBP1 Suppresses Polyglutamine- induced Neurodegeneration In Vivo  H Akiko Popiel, Yoshitaka Nagai, Nobuhiro.
Volume 3, Issue 5, Pages (May 2001)
Volume 16, Issue 4, Pages (April 2008)
Volume 18, Issue 10, Pages (October 2010)
Role of Cell-Penetrating Peptides in Intracellular Delivery of Peptide Nucleic Acids Targeting Hepadnaviral Replication  Bénédicte Ndeboko, Narayan Ramamurthy,
Molecular Therapy - Nucleic Acids
Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice  Mingxing Wang, Bo Wu, Sapana N. Shah, Peijuan.
Presentation transcript:

A High Throughput In Vivo Model for Testing Delivery and Antiviral Effects of siRNAs in Vertebrates  Brian Dall Schyth, Niels Lorenzen, Finn Skou Pedersen  Molecular Therapy  Volume 15, Issue 7, Pages 1366-1372 (July 2007) DOI: 10.1038/sj.mt.6300150 Copyright © 2007 The American Society of Gene Therapy Terms and Conditions

Figure 1 Verification of small interfering RNA (siRNA) functionality in human embryonic kidney 293T cells. (a) Two different siRNAs, siVHSV-G193 and siVHSV-G537, targeting the viral hemorrhagic septicamia virus glycoprotein (VHSV-G) were transfected with the expression vector pcDNA3-vhsG, which encodes VHSV-G. (b) Suppression of VHSV-G as evaluated by real-time polymerase chain reaction was approximately 75–80% compared with mock control cells treated with the transfection agent only. An siRNA targeting enhanced green fluorescent protein (EGFP) (Dharmacon) was used as specificity control. G protein intensity in 293T cells was evaluated by immunofluorescence of cells stained using rhodamin and antibodies specific to VHSV-G. Scale bar = 60 μm. (c) The specificity of siRNAs was also tested by transfection with an expression vector encoding the glycoprotein of the heterologous rhabdovirus infectious hematopoietic necrosis virus (IHNV). In all cases values are mean G messenger RNA levels from three wells normalized to the mock control + SD. Molecular Therapy 2007 15, 1366-1372DOI: (10.1038/sj.mt.6300150) Copyright © 2007 The American Society of Gene Therapy Terms and Conditions

Figure 2 In vivo uptake of fluorescein isothiocyanate–conjugated small interfering RNAs (siRNAs). Twenty-four hours after intraperitoneal (IP) injection of rainbow trout with 10 μg siRNA per gram body weight, 10-μm cryosections were made, counterstained with 4′-6-diamindino-2-phenylindole (DAPI), and examined. (a–d) The same area of the tissue section using a fluorescein isothiocyanate filter to detect fluorescent siRNAs (upper row) and a filter for DAPI (lower row) to visualize and identify specific tissues in the sections. Intestinal lumen (il), muscle tissue (m), liver (l), kidney (k), and IP cavity (ic). (a) Anterior of ic dorsal to intestine with fluorescent siRNAs mainly residing in cells lining the ic ventral to the kidney. (b–c) Fluorescent siRNAs were also seen in cavities between intestinal lobes. (c) Close-up of the space between intestinal blind sacks showing location of fluorescent cells. (d) Ic sections from fish injected with naked fluorescent siRNAs and (e) non-fluorescent 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)–formulated siRNAs, respectively, were used as controls. (f) Fluorescent siRNAs in the cytoplasm of an IP cell captured at ×100 magnification. Four fish per group were included in the analysis. Representative findings are displayed. Scale bars (a, b, d, e) = 1 mm, (c) = 500 μm, (f) = 40 μm. Molecular Therapy 2007 15, 1366-1372DOI: (10.1038/sj.mt.6300150) Copyright © 2007 The American Society of Gene Therapy Terms and Conditions

Figure 3 Free intraperitoneal (IP) cells harvested 24 hours after IP injection of (a) naked fluorescent small interfering RNAs (siRNAs) or (b) 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)–formulated fluorescent siRNAs, respectively, as described in Materials and Methods. Micrographs in the left column were taken by light microscopy and pictures to the right using a filter for detection of fluorescein isothiocyanate. Cells were harvested and inspected from three fish per group. Scale bars = 15 μm. Molecular Therapy 2007 15, 1366-1372DOI: (10.1038/sj.mt.6300150) Copyright © 2007 The American Society of Gene Therapy Terms and Conditions

Figure 4 Effect of intraperitoneal (IP) small interfering RNAs on development of mortality among rainbow trout fry following challenge with viral hemorrhagic septicemia virus (VHSV). (a) At day-1 fish were IP-injected with 0.9% NaCl, naked small interfering RNAs, and 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)–formulated siVHSV-G193 and siVHSV-G537, respectively. At day 0, virus was added to a final concentration of 105 tissue culture infectious dose50/ml in the aquarium water followed by daily monitoring of mortality. (b) An extended experiment included fish injected with DOTAP, fish injected with the DOTAP-formulated siRNA against enhanced green fluorescent protein (EGFP), and fish injected with two different doses of the DOTAP-formulated siVHSV-G193. In both experiments 30 fish were used per condition. Molecular Therapy 2007 15, 1366-1372DOI: (10.1038/sj.mt.6300150) Copyright © 2007 The American Society of Gene Therapy Terms and Conditions

Figure 5 Expression of the interferon (IFN)-induced antiviral guanosine triphosphatase Mx3 in rainbow trout liver following intraperitoneal (IP) injection of 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/small interfering RNAs (siRNA) formulations. RNA was purified from the liver of fish 48 hours after injection with the DOTAP/siRNA formulations. (a) Cryosections of liver counterstained with 4′-6-diamindino-2-phenylindole (top) show that delivery of siRNAs to this organ was below the detection limit. Scale bar = 1 mm. (b) Mx3 expression analysis by real-time polymerase chain reaction on liver tissue from fish IP-injected with polyinosinic:polycytidylic acid (polyI:C) (positive control), DOTAP control, the three DOTAP/siRNA formulations used throughout this study, and naked siVHSV-G193. Owing to the large variation in the expression data, groups were compared according to their median rather than their mean. N denotes the number of fish in each group. Molecular Therapy 2007 15, 1366-1372DOI: (10.1038/sj.mt.6300150) Copyright © 2007 The American Society of Gene Therapy Terms and Conditions

Figure 6 The delivery agent 1,2-dioleoyl-3-trimethylammonium propane (DOTAP) is able to increase the interferon-stimulatory potential of the toll-like receptor 3 ligand polyinosinic:polycytidylic acid (polyI:C). This concept was tested in rainbow trout (a) in vivo and (b) in vitro using rainbow trout gonad cells (RTG2). Trout were injected and processed as in the experiment corresponding to Figure 5. Injected reagents were polyI:C and DOTAP-formulated polyI:C, using saline and DOTAP alone as controls. Cell layers were transfected by the same reagents using only the DOTAP control. Expression analysis is as in Figures 1 and 5. Mean value from (a) four fish + SD or (b) three cell culture wells + SD. Readout for DOTAP alone was in both cases used for normalization. Molecular Therapy 2007 15, 1366-1372DOI: (10.1038/sj.mt.6300150) Copyright © 2007 The American Society of Gene Therapy Terms and Conditions